Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

June 25, 2020June 25, 2020

Groups Pledge Funding for Project to Develop Ovarian Cancer Blood Test

News

A team at Griffith University’s Institute for Glycomics in Australia has received $300,000 in funding from The Bourne Foundation, as well as a further funding pledge from Tour de Cure, to advance ... Read more

June 11, 2020June 11, 2020

Zejula-Bevacizumab Combo Delays Progression in Relapsed Ovarian Cancer, Trial Finds

News

A combination of bevacizumab and Zejula (niraparib) is significantly better than Zejula alone at extending the time without disease progression in people with platinum-sensitive relapsed ovarian cancer, findings from a clinical ... Read more

May 27, 2020May 27, 2020

Phase 2 Trial to Test Exercise as Way to Improve Quality of Life in Recurring Ovarian Cancer

News

A new Phase 2 clinical trial in Australia will assess whether exercise can improve the quality of life and physical function of women with recurring ovarian cancer who are on chemotherapy. ... Read more

February 17, 2020February 17, 2020

Analysis of Cells in Fallopian Tube Can Help Classify Ovarian Cancer Subtypes, Study Says

News

Analysis of cells in the fallopian tube, from which most ovarian cancers develop, can help classify ovarian cancer subtypes, with potential implications for cancer prognoses and treatment strategies, a new ... Read more

January 17, 2020

Large Study Finds No Strong Link Between Talc Powder and Ovarian Cancer Risk

News

After decades of conflicting evidence about the possible link between talc powder in the genital area and ovarian cancer, the largest study conducted to date has found no strong connection ... Read more

January 16, 2020January 22, 2020

First Participant Dosed in Phase 1 Trial of Tmunity’s CAR T-cell Therapy in Solid Tumors

News

The first participant has been dosed in a Phase 1 clinical trial evaluating Tmunity Therapeutics‘ CAR T-cell therapy, CART-TnMUC1, in people with certain solid tumors, including ovarian cancer, that are ... Read more

December 17, 2019January 21, 2020

Pivotal Trial of Mirvetuximab Soravtansine in Advanced Ovarian Cancer Levels Likely in 2020

News

ImmunoGen is planning to open an open-label, pivotal clinical trial of mirvetuximab soravtansine in platinum-resistant ovarian cancer patients with high levels of the folate receptor alpha (FRα) protein early next year, ... Read more

November 15, 2019

Ovarian Cancer Risk in Fertility Assistance Rises Mainly for Women with Endometriosis, Study Suggests

News

Women who require assisted reproductive technology to become mothers are not more likely to develop ovarian cancer, except for those with endometriosis, a new study suggests. The study, “Assisted reproductive ... Read more

November 11, 2019

CA125 Blood Test May Help Alert GPs to Ovarian and Other Cancers, Research Shows

News

Commonly used in primary healthcare, blood tests for CA125 may help diagnose ovarian cancer and other types of cancer, particularly in older individuals, new research suggests. The findings were described ... Read more

November 1, 2019

Zejula Maintenance Increases Time Without Symptoms or Toxicity in Recurrent OC Patients, Study Says

News

Taking Zejula (niraparib) as a maintenance therapy may increase time without symptoms or toxicities from treatment in women with recurrent ovarian cancer, a new study found. These results suggest that ... Read more